New perspectives on lamellar keratoplasty.
Lamellar (anterior and posterior) keratoplasty entails the surgical replacement of diseased-only corneal tissue, while healthy host corneal tissue is preserved. Selective keratoplasty offers several advantages in comparison to penetrating keratoplasty such as a lower rate of graft rejection, less endothelial cell loss, faster/superior visual rehabilitation and enhanced resistance to closed injury. The surgical approach of "partial corneal transplantation" may be divided into anterior and posterior: techniques including superficial and deep anterior lamellar keratoplasty (SALK and DALK, respectively) and endothelial keratoplasty as well as Descemet stripping automated endothelial keratoplasty (DSAEK) and Descemet membrane endothelial keratoplasty (DMEK). These novel surgical procedures are rapidly becoming the preferred therapy option for specific corneal dysfunctions involving the corneal stroma (SALK, DALK), or corneal endothelium (DSAEK, DMEK). During the past decade, the continuing advancement of surgical techniques and the development of innovative surgical instruments have significantly enhanced corneal transplantation. Lamellar keratoplasty techniques facilitate corneal surgery, provide patients with superior outcomes and can successfully restore vision in corneal-related blindness. Nevertheless, more long-term evidence is needed to better evaluate these promising new techniques.
Vardinoyiannion Eye Institute of Crete (VEIC), Faculty of Medicine, University of Crete, Heraklion, Crete, Greece.
George D
GD
Kymionis
Dimitrios G
DG
Mikropoulos
Dimitra M
DM
Portaliou
Kostantinos G
KG
Boboridis
Irini C
IC
Voudouragkaki
Nikolaos D
ND
Dragoumis
Anastasios G P
AG
Konstas
D003315:Cornea / Q000473:pathology / Q000601:surgery; D003316:Corneal Diseases / Q000175:diagnosis / Q000473:pathology / Q000601:surgery; D016039:Corneal Transplantation / Q000009:adverse effects / Q000379:methods / Q000639:trends; D004728:Endothelium, Corneal / Q000637:transplantation*; D006084:Graft Rejection / Q000517:prevention & control; D006801:Humans; D062069:Inventions; D059351:Organ Sparing Treatments